Published in:
Open Access 01-10-2017 | Erratum
Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
Published in: Diabetes Therapy | Issue 5/2017
Login to get accessExcerpt
In the original publication, corresponding author e-mail address and Fig. 2 were published incorrectly. The correct e-mail address and the revised Fig. 2 are given here.
Fig. 2
Proposed algorithm for adjusting antidiabetic agents (a) and diuretic/antihypertensive therapy (b) when initiating SGLT2 inhibitors in patients with type 2 diabetes. DPP4i DPP4 inhibitors, GI gastrointestinal, GLP1ra GLP-1 receptor agonists, SU sulfonylureas, SMBG self-monitoring of blood glucose, BP blood pressure. *Avoid insulin withdrawal to minimize the risk of euglycemic diabetic ketoacidosis. **Hemodynamically unstable defined as atrial fibrillation, orthostatic hypotension or blood pressure lability, prior syncope, etc. ***Clinical situation defined by congestive heart failure, edema, renal function
× ![]()
…